Download Background of Cell-Free Protein Synthesis

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

DNA vaccination wikipedia , lookup

Polycomb Group Proteins and Cancer wikipedia , lookup

Gene therapy of the human retina wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Point mutation wikipedia , lookup

Nicotinic acid adenine dinucleotide phosphate wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

Protein moonlighting wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

NEDD9 wikipedia , lookup

Transcript
SINGAPORE
Home › Products › Protein Expression & Purification Technologies › Cell-Free Expression › Cell-Free Expression › Background of Cell-Free Protein Synthesis
Background of Cell-Free Protein Synthesis
< Return to Cell-Free Expression
Since the early pioneering work of Nirenberg and Matthaei in 1961 (1), which demonstrated in vitro protein translation using cell extracts, cellfree protein synthesis has become an important tool for molecular biologists by playing a central role in a wide variety of applications (2). In
the post-genomic era, cell-free protein synthesis has the potential to become one of the most important high throughput technologies for
functional genomics and proteomics.
The biggest advantage, compared to protein production in living cells, is that cell-free protein synthesis is the quickest way to obtain an
expressed phenotype (protein) from a genotype (gene). Starting with a PCR or plasmid template, in vitro protein synthesis and functional
assays can be carried out in a few hours. Moreover, it is independent of host cells. Proteins which are toxic or prone to proteolytic
degradation can be readily prepared in vitro.
Commercially available cell-free protein synthesis systems are typically derived from cell extracts of Escherichia coli S30, rabbit
reticulocytes or wheat germ. The drawback of extract-based systems is that they often contain nonspecific nucleases and proteases that
adversely affect protein synthesis. In addition, the cell extract is like a “black box” in which numerous uncharacterized activities may modify
or interfere with subsequent downstream assays.
Some of these limitations can be partially overcome, for instance, by using engineered strains or by adding various inhibitors. Nevertheless,
the problems cannot be solved at the root level.
References
1. Nirenberg, M.W. and Matthaei, J.H. (1961) Proc. Natl. Acad. Sci. USA, 47, 1588–1602. PMID: 14479932
2. Katzen, F., Chang, G. and Kudlicki, W. (2005) Trends. Biotechnol. 23, 150–156. PMID: 15734558
Learn about Cell-Free Expression
Advantages of the PURE System
Applications of the PURE System
Background of Cell-Free Protein Synthesis
The PURE Approach